Effect of Peptide-Chelate Architecture on Metabolic Stability of Peptide-based MRI Contrast Agents
Vertical Tabs
New J Chem
2010 Feb 12
2010
34
611-616
10.1039/b9nj00787c
Journal Articles
PubMed ID:
20526382
A strategy for preparing high relaxivity, metabolically stable peptide-based MR contrast agents is described.
Year:
2010
